协助胃肠道诊断实验室设计一种用于非侵入性检测胃的装置
Mehwish Faiz1, Maheen Murad1, Rabia Khalid1
1Department of Biomedical Engineering, Ziauddin University, Faculty of Engineering, Science, Technology and Management (ZUFESTM), Karachi, Sindh, Pakistan.
概括
这项研究引入了一种非侵入性装置,通过监测生命体征和唾液pH值来检测胃潰瘍,有助于早期检测Helicobacter pylori. 这种方法为传统的诊断程序提供了一种无痛的替代方案.
科学领域:
- 胃肠病学 胃肠病学
- 生物医学工程 生物医学工程
- 医学诊断 医学诊断 医学诊断
背景情况:
- 胃潰瘍病 (PUD) 是一種嚴重的胃腸問題,影響胃和十二指腸,經常與Helicobacter pylori (H. pylori) 感染有關.
- 目前用于PUD的诊断方法是侵入性的,痛苦的,并且不是普遍可用的.
- 非侵入性地识别H. pylori对于及时管理PUD至关重要.
研究的目的:
- 开发和验证一种用于检测胃潰瘍的非侵入性设备.
- 通过监测关键生理参数来确定H. pylori的存在.
- 提供一种可行且易于使用的胃病诊断工具.
主要方法:
- 监测呼吸率,心率,心电图,唾液pH和体温.
- 获取生物信号作为模拟输入,并使用MCP3008.8将其转换为数字.
- 使用Raspberry Pi 3处理数字输入以进行分析和输出显示.
主要成果:
- 观察到心率,温度和呼吸率等物理化学参数的升高.
- 唾液的pH值下降到酸性方面,并注意到心电图的QRS复合物的干扰.
- 该设备成功地将获得的参数值与标准值进行了比较,以确定胃的存在.
结论:
- 开发的非侵入性设备通过分析生理变化,有效地识别胃.
- 监测呼吸速率,心率,心电图,唾液pH值和温度提供了一种可靠的方法来检测H. pylori.
- 这项技术为诊断胃潰瘍疾病提供了一个有希望的,非侵入性的替代方案.
相关概念视频
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
159
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
159
01:26Peptic Ulcer Disease IV: Management
115
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
115
01:30Peptic Ulcer Disease I: Introduction
215
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
215
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
474
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
474
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
646
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
646
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
508
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
508